Delivery Order SPE2DB22D3004-SPE2DB24FPF14
- Not listed
- This federal contract award, valued at $4,222.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of May 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
- This federal contract award, with a ceiling value of $3,071.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a pharmaceutical product. This award is a delivery order under the parent company Cencora, Inc.'s Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award, valued at $2,095.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc....
- This federal contract award, valued at $2,413.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a prescription medication, with a completion date of December 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $5,843.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product, with a completion date of February 15, 2024. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, has a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a ceiling value of $6,906.06 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $7,653.68, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of January 30, 2024. This award is associated with a larger Indefinite...
- This federal contract award, valued at $2,245.33, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Advair HFA 115-21 MCG Inhaler, a critical pharmaceutical product, to support military healthcare programs. The contract, which has a period of performance through February 15, 2024, is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, for a ceiling value of $5,492.53. The contract has a completion date of February 29, 2024 and is a firm fixed-price contract. This order is part of Amerisourcebergen's significant...
- This federal contract award, valued at $2,342.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of Advair HFA 115-21 mcg inhalers, a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 11, 2024. This award is part of a larger...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPF14Delivery Order
This federal contract award, valued at $3,282.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 115-21 MCG inhalers, a prescription pharmaceutical product. The contract has a period of performance ending on February 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 2/5/24 |